The Landscape of GLP-1 Prescriptions in Germany: A Comprehensive GuideThe pharmaceutical landscape in Germany has undergone a considerable shift over the last 2 years, driven mainly by the international surge in demand for GLP-1 (Glucagon-like peptide-1) receptor agonists. Originally established to deal with Type 2 diabetes, these medications have actually
